TAG
Jim Cramer
Jim Cramer: Abbott stock is ‘dirt cheap’ after a surprising legal win validates our conviction
Abbott Laboratories shares jumped Friday after the Club holding picked up a surprise victory in a trial over the safety of its formula...
Palo Alto shares helped by contract news, Abbott Labs braces for lawsuit ruling
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last...
We’re hiking our GEHC price target, looking beyond a mixed quarter to next year’s catalysts
GE Healthcare reported a mixed quarter before Wednesday's opening bell. While revenue slightly missed, an earnings beat along with a number of other...
Danaher returns a key business to growth, and we’re raising our stock rating back to buy
Danaher shares declined Tuesday despite the life sciences company returning its key bioprocessing business to growth in the third quarter. Danaher's revenue for...
Embattled Abbott Labs comes through with a strong quarter, buyback announcement
Medical device maker Abbott Laboratories on Wednesday delivered better-than-expected quarterly results and upped its earnings guidance for the third straight quarter. Shares rose...
What happened Friday hasn’t happened in ages. It bodes well for earnings
Something different happened Friday – so different that it took my breath away. The first Friday of earnings season has recently been such...
Jim Cramer lists 10 stocks on the S&P 500 that notched the biggest gains in the past two years
For roughly the past two years, traders have bullishly invested in companies on the S&P 500, leading the index of 500 large U.S....
GE Healthcare has been an under-the-radar winner — and a new catalyst just arrived
GE Healthcare 's quiet outperformance is becoming harder to tune out — and its new drug used in radiology to improve the diagnosis...
10 things to watch in the stock market Friday including a bullish call on Best Buy
10 things to watch Friday, Sept. 27 1. The S & P 500 was looking at a slightly higher open Friday after another...
Why Eli Lilly and Palo Alto Networks are both up on news from their competitors
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last...